Azitra Inc., a biopharmaceutical company that’s developing treatments for skin diseases, filed for an initial public offering on Tuesday with ThinkEquity...
Azitra Inc., a biopharmaceutical company that’s developing treatments for skin diseases, filed for an initial public offering on Tuesday with ThinkEquity acting as sole underwriter on the deal. The Branford, Connecticut-based company will use the proceeds of the deal to fund clinical trials and product development, including $2.5 million that’s earmarked for the ATR-12 Netherton syndrome program, which will provide funding for dosing in a proposed Phase 1b trial.
The Branford, Connecticut-based company will use the proceeds of the deal to fund clinical trials and product development, including $2.5 million that’s earmarked for the ATR-12 Netherton syndrome program, which will provide funding for dosing in a proposed Phase 1b trial. Netherton is a rare disorder that causes severe inflammation, scaling, red and dehydrated skin, for which there is currently no FDA-approved treatment option. The company, like many early-stage biotechs, is loss-making.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
BioCube plants life science flag in North San Jose - Silicon Valley Business JournalBioCube’s Tony Gonzalez thinks San Jose is a great place for biotech firms to call home.
Leer más »
BioCube plants life science flag in North San Jose - Silicon Valley Business JournalBioCube’s Tony Gonzalez thinks San Jose is a great place for biotech firms to call home.
Leer más »
Goldman Sachs upgrades Vir Biotechnology, says shares can more than double post-CovidThe firm said the immunology company will release new flu vaccine data in the year ahead that could drive growth for the biotech stock.
Leer más »
China formalizes rules for overseas IPOsThe new rules also call for IPO underwriters, typically international investment banks, to annually report to the CSRC their involvement with Chinese listings overseas.
Leer más »
Going Private Again Is All the Rage Among Newly Public CompaniesTen companies that went public in 2020 or 2021 have already agreed to go private in another sign of a post-IPO-boom hangover.
Leer más »
Elusive Chinese Billionaire Jack Ma Spotted In Australia, Report SaysMa has almost completely disappeared from public view after Chinese regulators shut down his fintech company Ant Group’s IPO in late 2020.
Leer más »